Clinical research and clinical trials

How are we going?

  • Dora Inés Molina de Salazar Universidad de Caldas (Manizales, Colombia)
  • Sandra Milena Botero Universidad de Caldas (Manizales, Colombia)
  • Germán Camilo Giraldo Universidad de Caldas (Manizales, Colombia)

Abstract

Due to the rise in the number of clinical trials sponsored by the pharmaceutical industry, its importance to economic, academic and public health level, an update on the development of clinical research at the level of the world, Latin America and Colombia is made, where the number of clinical trials to June 2016 according to ClinicalTrials.gov, continents and countries with greater participation, current challenges for driving the same and the main motivations of patients to accept or reject participation in clinical research is described.

Metrics

Metrics Loading ...

Author Biographies

Dora Inés Molina de Salazar, Universidad de Caldas (Manizales, Colombia)

Docente Titular Facultad de Ciencias para la Salud, Universidad de Caldas. Investigadora Principal IPS Médicos Internistas de Caldas

Sandra Milena Botero, Universidad de Caldas (Manizales, Colombia)

Subinvestigadora IPS Médicos Internistas de Caldas

How to Cite
Molina de Salazar, D. I., Botero, S. M., & Giraldo, G. C. (1). Clinical research and clinical trials: How are we going?. Acta Medica Colombiana, 41(3S), 43-50. Retrieved from https://www.actamedicacolombiana.com/ojs/index.php/actamed/article/view/2299
Issue
Vol. 41 No. 3S (2016): Proceedings of the XXIV Colombian Congress of Internal Medicine
Section
Original works

Acta Medica Colombiana uses the CC-BY 4.0 license. Authors retain all rights over their work.

Most read articles by the same author(s)